Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
Shaji Kumar(Mayo Clinic in Arizona), Jesús G. Berdeja(Sarah Cannon), Rubén Niesvizky(NewYork–Presbyterian Hospital), Sagar Lonial(Emory University), Jacob P. Laubach(Dana-Farber Cancer Institute), Mehdi Hamadani(West Virginia University), A. Keith Stewart(Mayo Clinic in Arizona), Parameswaran Hari(Medical College of Wisconsin), Vivek Roy(WinnMed), Robert Vescio(Cedars-Sinai Medical Center), Jonathan L. Kaufman(Emory University), Deborah Berg(Millennium Engineering and Integration (United States)), Eileen Liao(Takeda (United States)), Alessandra Di Bacco(Millennium Engineering and Integration (United States)), Jose Estevam(Takeda (United States)), Neeraj Gupta(Millennium Engineering and Integration (United States)), Ai-Min Hui(Takeda (United States)), S. Vincent Rajkumar(Mayo Clinic in Arizona), Paul G. Richardson(Dana-Farber Cancer Institute)
Cited by 264
Abstract
Related Papers
No related papers found
Powered by citation graph analysis